Sunshine Biopharma (NQ: SBFM )

2.690 -0.030 (-1.10%)
Streaming Delayed Price Updated: 3:59 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 76,126
Open 2.740
Bid (Size) 2.650 (3)
Ask (Size) 2.770 (10)
Prev. Close 2.720
Today's Range 2.650 - 2.790
52wk Range 2.420 - 637.20
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%
Via ACCESSWIRE
Sunshine Biopharma Launches Two New Generic Prescription Drugs
Via ACCESSWIRE

Performance

YTD
-99.51%
-99.51%
1 Month
-10.33%
-10.33%
3 Month
-2.89%
-2.89%
6 Month
-84.93%
-84.93%
1 Year
-99.50%
-99.50%

More News

Read More
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
Via FinancialNewsMedia
Exposures COVID-19
Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry
Via ACCESSWIRE
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
From FN Media Group LLC
Via GlobeNewswire
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031
Via FinancialNewsMedia
Exposures COVID-19
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031
From FN Media Group LLC
Via GlobeNewswire
SUNSHINE BIOPHARMA ANNOUNCES PUBLICATION OF SIGNIFICANT CORONAVIRUS RESEARCH RESULTS IN THE JOURNAL OF MEDICINAL CHEMISTRY
Via FinancialNewsMedia
Exposures COVID-19
Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada
Via ACCESSWIRE
Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%
Via ACCESSWIRE
SBFM Stock Earnings: Sunshine Biopharma Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Sunshine Biopharma Announces Reverse Stock Split
Via ACCESSWIRE
7 F-Rated Growth Stocks to Avoid Right Now: June 2024
Via InvestorPlace
3 Penny Stocks Ready to Explode Into Dollar Signs by 2028
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why KKR Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54%
Via ACCESSWIRE
SBFM Stock Earnings: Sunshine Biopharma Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
3 Meme Stocks to Sell That Even Roaring Kitty Can’t Save
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.